Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/7947
Title: | Resveratrol disrupts peroxynitrite-triggered mitochondrial apoptotic pathway: a role for Bcl-2 | Authors: | Brito, Paula Simões, Núria Almeida, Leonor Dinis, Teresa |
Issue Date: | 2008 | Citation: | Apoptosis. 13:8 (2008) 1043-1053 | Abstract: | Abstract Resveratrol (3,4',5-trihydroxystilbene) is a phytochemical believed to be partly responsible for the cardioprotective effects of red wine due to its numerous biological activities. Here, we studied biochemical pathways underlying peroxynitrite-mediated apoptosis in endothelial cells and potential mechanisms responsible for resveratrol cytoprotective action. Peroxynitrite triggered endothelial cell apoptosis through caspases-8, -9 and -3 activation implying both mitochondrial and death receptor apoptotic pathways. Resveratrol was able to prevent peroxynitrite-induced caspases-3 and -9 activation, but not caspase-8 activation. Additionally, peroxynitrite increased intracellular levels of Bax without affecting those of Bcl-2, increasing consequently the Bax/Bcl-2 ratio. This ratio decreased when cells where pre-incubated with 10 and 50 µM resveratrol, mainly due to resveratrol ability per se to increase Bcl-2 intracellular levels without affecting Bax intracellular levels. These results propose an additional mechanism whereby resveratrol may exert its cardioprotective effects and suggest a key role for Bcl-2 in the resveratrol anti-apoptotic action, especially in disrupting peroxynitrite-triggered mitochondrial pathway. | URI: | https://hdl.handle.net/10316/7947 | DOI: | 10.1007/s10495-008-0235-4 | Rights: | openAccess |
Appears in Collections: | FFUC- Artigos em Revistas Internacionais |
Show full item record
SCOPUSTM
Citations
32
checked on Oct 28, 2024
WEB OF SCIENCETM
Citations
5
31
checked on Oct 2, 2024
Page view(s) 50
639
checked on Oct 29, 2024
Download(s)
300
checked on Oct 29, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.